In 2025, Radboudumc Business Development secured over €1.4 million in funding to support Radboudumc’s participation in the national Biotech Booster program. This funding strengthens Radboudumc’s contribution to a nationwide valorization network that helps accelerate promising biotech innovations towards real-world application.
About Biotech Booster
Biotech Booster is a national program that supports the translation of academic biotech discoveries into validated solutions with real-world impact. It brings together universities, university medical centers and partners across the Netherlands to provide funding, expertise and a structured pathway from early-stage innovation towards further development and implementation. Radboudumc brings value to the different projects within Biotech Booster with scientific knowhow and application advice whcih already resulted in several collaborations. In addition, Radboudumc benefits from the broad expertise within the Biotech Booster network and up to now 3 Radboudumc proof of principle projects received funding of €200,000 each.
Three Radboudumc projects awarded within Biotech Booster
Malaria Vaccine
More information: biotechbooster.nl/projects/malaria-vaccine
Radboudumc is developing a malaria transmission-blocking vaccine candidate. The approach aims to prevent transmission of the parasite to mosquitoes, contributing to reducing spread and supporting long-term control efforts.
T-Guard
More information: biotechbooster.nl/projects/t-guard
T-Guard is a therapeutic approach designed to selectively eliminate overactive immune cells involved in severe immune-related diseases. The project aims to move this innovation closer to clinical development and future patient impact.
Dual Tumor Targeting
More information: biotechbooster.nl/projects/dual-tumor-targeting
This project focuses on a new targeted anti-cancer strategy aimed at improving tumor selectivity and treatment effectiveness. Biotech Booster support helps advance the pathway towards further development and translation.
For more information about these projects or potential collaboration opportunities, please contact Radboudumc Business Development via businessdevelopment@radboudumc.nl.
For future open calls and internal information, visit: Radboudumc Intranet – Valorisation.
More information about the program and the full project overview is available via Biotech Booster.
Related news items
ATRO Medical starts unique meniscus study
1 November 2024As the first worldwide, ATRO Medical is starting a clinical study on the function of an artificial outer meniscus, the lateral meniscus. This is a first: never before has a removed lateral meniscus been replaced by a plastic specimen, the Artimis® Meniscus Prosthesis.
go to page
Meet Healthy Ideas, Healthy Returns
2 June 2023Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.
go to pageAftermovie Investment Day 2022 and a new date for 2023!
13 December 2022Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.
go to pageJoining forces increases innovation Janssen and Radboud
1 December 2022Dr. Eng Kinga Matuła (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.
go to page
Successful matchmaking at Radboudumc Investment Day
7 October 2022On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.
go to page